J. Buciak

发表

Human Insulin Receptor Monoclonal Antibody Undergoes High Affinity Binding to Human Brain Capillaries in Vitro and Rapid Transcytosis Through the Blood–Brain Barrier in Vivo in the Primate

W. Pardridge, Young-Sook Kang, J. Buciak, 1995, Pharmaceutical Research.

Transport of histone through the blood-brain barrier.

W. Pardridge, J. Buciak, D. Triguero, 1989, The Journal of pharmacology and experimental therapeutics.

Drug delivery of antisense oligonucleotides or peptides to tissues in vivo using an avidin–biotin system

W. Pardridge, J. Buciak, R. Boado, 1993 .

Transport of Human Recombinant Brain-Derived Neurotrophic Factor (BDNF) Through the Rat Blood−Brain Barrier in Vivo Using Vector-Mediated Peptide Drug Delivery

W. Pardridge, Young-Sook Kang, J. Buciak, 1994, Pharmaceutical Research.

Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo.

W. Pardridge, P. Friden, J. Buciak, 1991, The Journal of pharmacology and experimental therapeutics.

Measurement of Free Intracellular and Transfer RNA Amino Acid Specific Activity and Protein Synthesis in Rat Brain in vivo

W. Pardridge, J. Buciak, Katharine M. Hargreaves-Wall, 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Enhanced cellular uptake and in vivo biodistribution of a monoclonal antibody following cationization.

W. Pardridge, Y. Kang, J. Buciak, 1995, Journal of pharmaceutical sciences.

Measurement of Amyloid Peptide Precursor of Alzheimer Disease in Human Blood by Double Antibody Immunoradiometric Assay

H. Vinters, B. Miller, W. Pardridge, 1991, Alzheimer disease and associated disorders.

Differential expression of 53- and 45-kDa brain capillary-specific proteins by brain capillary endothelium and choroid plexus in vivo and by brain capillary endothelium in tissue culture

W. Pardridge, J. Buciak, Jing Yang, 1990, Molecular and Cellular Neuroscience.

Cationization of immunoglobulin G results in enhanced organ uptake of the protein after intravenous administration in rats and primate.

W. Pardridge, J. Buciak, D. Triguero, 1991, The Journal of pharmacology and experimental therapeutics.

Beta-endorphin chimeric peptides: transport through the blood-brain barrier in vivo and cleavage of disulfide linkage by brain.

W. Pardridge, J. Buciak, D. Triguero, 1990, Endocrinology.

Capillary Depletion Method for Quantification of Blood–Brain Barrier Transport of Circulating Peptides and Plasma Proteins

W. Pardridge, J. Buciak, Domingo Triguero, 1990, Journal of neurochemistry.

Protamine-mediated transport of albumin into brain and other organs of the rat. Binding and endocytosis of protamine-albumin complex by microvascular endothelium.

W. Pardridge, Y. Kang, J. Buciak, 1993, The Journal of clinical investigation.

Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector.

W. Pardridge, J. Buciak, Jing Yang, 1990, The Journal of pharmacology and experimental therapeutics.

Transport of recombinant CD4 through the rat blood-brain barrier in vivo.

W. Pardridge, J. Buciak, T. Yoshikawa, 1992, The Journal of pharmacology and experimental therapeutics.

Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex.

W. Pardridge, J. Buciak, Jing Yang, 1995, Proceedings of the National Academy of Sciences of the United States of America.